Peripheral Nerve Injuries Clinical Trial
Official title:
Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy, and Improve Functional Outcomes Following Peripheral Nerve Injury
The aim of this clinical trial is to assess the efficacy of tesamorelin as a therapy for peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will allow for faster and greater recovery of motor and sensory function following surgical repair of injured peripheral nerves. Patients with upper extremity nerve injuries will be randomly assigned to receive either the drug or a placebo (inactive drug). A number of tests for nerve regeneration, muscle function and sensation will be performed every month for a total of 12 months. Outcomes in the patients treated with tesamorelin will be compared to outcomes in patients who received the placebo to determine the effectiveness of tesamorelin as a therapy for nerve injuries.
This is a multi-institutional, randomized, double-blinded, placebo-controlled clinical trial assessing the efficacy of tesamorelin as a therapy to improve functional recovery following peripheral nerve injury. Tesamorelin is a drug that stimulates increased production of growth hormone, and growth hormone has been shown to improve nerve regeneration and functional recovery in animal studies. A total of 36 participants with repaired ulnar nerve lacerations will be enrolled, of which 18 will be randomly assigned to receive the study drug and 18 will receive the placebo. To avoid bias, the study participants and investigators will be blinded to the treatment group assignments. Following enrollment, each participant will have 12 monthly follow-up visits during which participants will undergo testing to assess recovery. Outcome assessments will include clinical exams, MRI, electrodiagnostic studies and questionnaires. The total duration of the study is expected to be 4 years. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04572906 -
Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries
|
Phase 2 | |
Active, not recruiting |
NCT03999424 -
Autologous Human Schwann Cells in Peripheral Nerve Repair
|
Phase 1 | |
Not yet recruiting |
NCT05848778 -
Non-invasive Therapy to Drive Nerve Regeneration
|
N/A | |
Completed |
NCT02070367 -
Somatosensory Assessment and Rehabilitation of Allodynia (SARA)
|
N/A | |
Recruiting |
NCT03205124 -
The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration.
|
Phase 2/Phase 3 | |
Recruiting |
NCT01526681 -
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
|
||
Recruiting |
NCT03422107 -
Somatosensory Evoked Potential (SSEP) Monitoring for Detection of Intraoperative Positional Neuropraxia
|
N/A | |
Active, not recruiting |
NCT05339594 -
REINVENT Registry (Registry of the Nerve Gap Repair From Integra)
|
||
Completed |
NCT02437695 -
Robot Assisted Radical Prostatecomy and Positional Injury
|
N/A | |
Completed |
NCT02786888 -
Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle
|
N/A | |
Completed |
NCT01954199 -
The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain
|
N/A | |
Withdrawn |
NCT02095899 -
Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome
|
Phase 2 | |
Recruiting |
NCT02403661 -
Electrical Stimulation to Enhance Peripheral Nerve Regeneration
|
N/A | |
Completed |
NCT03191032 -
Early Sensory Re-education of the Hand With a Sensor Glove Model
|
N/A | |
Recruiting |
NCT06209801 -
Mirror Therapy Integrated With Electrical Stimulation for Cortical Modulations
|
N/A | |
Recruiting |
NCT03913689 -
StimRouter Registry Clinical Protocol
|
||
Terminated |
NCT02459015 -
Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions
|
N/A | |
Recruiting |
NCT03780855 -
Preliminary Evaluation of the Clinical Safety and Effectiveness of the Bionic Nerve Scaffold
|
N/A | |
Recruiting |
NCT05884125 -
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
|
N/A | |
Recruiting |
NCT04789044 -
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
|
Phase 2 |